Ratings Brenntag SE

Equities

BNR

DE000A1DAHH0

Market Closed - Xetra 16:35:29 12/07/2024 BST 5-day change 1st Jan Change
63.92 EUR +0.92% Intraday chart for Brenntag SE -0.12% -23.19%

Strengths

  • The stock, which is currently worth 2024 to 0.67 times its sales, is clearly overvalued in comparison with peers.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-23.19% 10.06B
B
+11.90% 83.57B
B
-8.46% 43.46B
A-
+5.13% 33.82B
C
+15.93% 19.17B
B
+9.82% 11.6B
A-
-11.52% 9.57B -
-3.66% 8.48B
C-
+6.99% 8.33B
B
-13.07% 5.45B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes